Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

• Status: Completed
• Trial end date: 2005-04-01
• Target enrollment: 0
• Participant gender: All

Summary

An eight week comparison of the investigational drug GW590735, placebo, and the marketed drug fenofibrate intended to increase the levels of "good cholesterol" and decrease levels of "bad cholesterol" in healthy patients with low levels of good cholesterol and high levels of bad cholesterol.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fenofibrate

Criteria

Inclusion criteria:

• High-density lipoprotein cholesterol less than or equal to 45 mg/dL.

• Triglycerides greater than or equal to 120 mg/dL and less than or equal to 500 mg/dL.

• Women must be surgically sterile or postmenopausal.

Exclusion criteria:

• Heart disease

• Diabetes